Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-01-27 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于召开2019年第二次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2019 second extraordinary general meeting of shareholders for 嘉事堂药业股份有限公司. It includes information about the meeting's date, location, agenda items (such as increasing business scope and amending company bylaws), voting procedures (including onsite and online voting), registration details, and proxy authorization forms. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and notice for a shareholder meeting. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting arrangements rather than the solicitation materials or proxy statement, it aligns best with the Proxy Solicitation & Information Statement (PSI) category, which covers materials sent to shareholders to provide information and request votes for meetings.
2019-01-27 Chinese
关于修改公司章程的公告
Governance Information Classification · 95% confidence The document is an announcement regarding the modification of the company's articles of association (company bylaws). It details changes to specific clauses and mentions that the proposal will be submitted to the shareholders' meeting for approval. The document is relatively short (1407 characters) and serves as a formal public notice of these changes rather than the full text of the amended articles or a detailed governance report. It does not contain financial data, audit information, or detailed governance practices but is focused on corporate governance changes. This fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices. The document is not a full annual report, audit report, or management report, nor is it a proxy solicitation or voting results announcement. Therefore, the classification is CGR with high confidence.
2019-01-27 Chinese
第五届董事会第二十九次临时会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting, including proposals to increase the company's business scope, amend the company bylaws, and convene a shareholders meeting. It details voting results and procedural compliance but does not contain financial statements or detailed financial data. The document is short (1529 characters) and serves as a formal announcement of board decisions rather than a full report or financial disclosure. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2019-01-27 Chinese
2019年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2019 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It details the legality and compliance of the meeting's convening, attendance, voting procedures, and resolutions passed, including approval of non-public stock issuance and related matters. The document is not a financial report, earnings release, or management discussion, but a legal opinion on the shareholder meeting and its resolutions. It contains detailed voting results and legal compliance statements. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and related shareholder meeting information. The document length (9498 characters) and content confirm it is the full legal opinion and voting results, not just an announcement of a report or a brief notice. Therefore, the correct classification is DVA with high confidence.
2019-01-03 Chinese
2019年第一次临时股东大会会议决议暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions and voting results from the 2019 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It includes voting outcomes on multiple proposals related to non-public stock issuance, fund usage, appointment of auditors, and shareholder return plans. The document also mentions the legal opinion from a law firm confirming the legality and validity of the meeting and resolutions. The content is focused on the official results of shareholder votes at a general meeting, including detailed vote counts and percentages, and the document is titled as a meeting resolution and voting results announcement. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 7449 characters, which is substantive and contains detailed voting data, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2019-01-03 Chinese
详式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司详式权益变动报告书" which translates to "Detailed Equity Change Report of Jia Shi Tang Pharmaceutical Co., Ltd." It is a detailed report about the change in equity holdings by China Everbright Group Ltd. (中国光大集团股份公司) in Jia Shi Tang Pharmaceutical Co., Ltd. The document includes sections on the equity change situation, purpose, procedures, shareholding before and after the change, agreements related to the equity change, funding sources, and future plans. It also references relevant Chinese laws and regulations governing equity changes and disclosures. The document is comprehensive and contains detailed financial and corporate information related to the equity change. This matches the definition of a "Major Shareholding Notification" which involves notification of changes in significant share ownership levels (crossing thresholds). The document is not an announcement of a report publication, nor is it a general regulatory filing or a financial report. Therefore, the appropriate classification is "MRQ" for Major Shareholding Notification.
2018-12-18 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.